Company intelligence / Profile preview
PDC Therapeutics
Epalinges, Vaud, Switzerlandpdcbio.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
PDC Therapeutics SA develops smart nanomedicines based on proprietary polymer-drug conjugate platforms for targeted cancer therapy. Their lead asset has entered Phase I clinical trials in patients with advanced solid tumors, showing strong translational results so far. The company’s pipeline includes additional oncology assets at various preclinical stages. Their Sagitta® platform enables precise targeting and controlled drug release to improve therapeutic index and tolerability compared to conventional therapies. They collaborate actively with multinational pharma partners and offer their technology for licensing/co-development opportunities.
- Therapeutic areas
- Oncology
- Modalities
- Polymer-drug conjugates (PDCs)nanomedicines
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Multinational pharmaceutical companies via co-development agreements; specific names not disclosed.
Beyond the preview
Go deeper on PDC Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PDC Therapeutics.